60 results
Page 2 of 3
6-K
EX-99.1
ps2wc
13 May 22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am
6-K
EX-1.1
cgbswfo
19 Apr 22
Open Market Sale Agreementsm
4:05pm
424B5
p811nkldfbh3
19 Apr 22
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
iksln
14 Apr 22
Notice of Annual Meeting of Shareholders
4:45pm
F-3
EX-5.1
puzv uzoup
7 Apr 22
Shelf registration (foreign)
5:30pm
20-F/A
gk5po44k5c x1hlzyi
7 Apr 22
Annual report (foreign) (amended)
4:06pm
6-K
EX-99.1
j662xf6n
30 Mar 22
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
7:53am
6-K
EX-99.1
unrn vxg97w3e563ds
5 Jan 22
Current report (foreign)
9:03am
6-K
EX-99.1
iqm9 ux3cbvh8x7mhdfn
16 Nov 21
Current report (foreign)
4:05pm
6-K
EX-99.1
2j16r8 cnevxrxeef
12 Nov 21
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
12:00am
6-K
EX-99.1
e271efw
9 Sep 21
Current report (foreign)
11:29am
6-K
EX-99.1
oskfc8kk5q7eiopjl
4 Aug 21
Current report (foreign)
7:17am
6-K
EX-99.1
d1rem lmbxtg5
4 Aug 21
Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights
7:16am
6-K
EX-99.1
4r4dady6yd4vvog
28 Jun 21
Current report (foreign)
8:16am
6-K
EX-99.1
40iq9afr4tt rx
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am